City View Green, CB2 Insights, Osoyoos Cannabis & Cannabis One
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION
SERVICE
TORONTO, March 05, 2019 (GLOBE NEWSWIRE) -- Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company")
is pleased to provide an update to investors.
City View Green To Commence Trading
Quinsam provided an early stage second mortgage financing to City View Green Holdings Inc. (CSE-CVGR) and
Quinsam continues to hold the mortgage on the Brantford-based property. As part of its investment, Quinsam received a 30%
equity stake in the company, which has been diluted down as a result of subsequent financings. City View Green is expected to
commence trading on March 5. At this time Quinsam holds approximately 26 million shares in the company. Quinsam had
previously reported that it would hold about 33 million shares in CVGR. However, this figure was reduced following a
pre-listing share consolidation. Our percentage holding in the company was not impacted.
CVGR has made great progress and is now pursuing an oil extraction strategy. It also holds a 19.99% stake in
Budd Hutt Inc., a private company pursuing cannabis retail licences in Alberta. We expect the company to announce
enhancements to its management team in the near term.
CB2 Insights To Commence Trading
CB2 Insights Inc. is the new name of MVC Technologies Inc. (dba Sail Cannabis). Trading is expected to
begin on Wednesday under the symbol CBII. Quinsam invested $440,000 at $0.44 per unit in the company last year.
CB2 Insights works to help mainstream cannabis grow into traditional healthcare through objective, real-world
evidence driven from its wholly-owned clinical division. With more than 300,000 patient interactions to-date, the company is able
to apply standard data collection protocols and track the efficacy of cannabis treatments in a way currently not available within
the cannabis industry today. CB2 owns and operates the largest and longest-running, multi-jurisdictional medical cannabis
evaluation and education centres serving 12 states across the US. CB2 has an aggressive medical cannabis clinic consolidation
strategy and anticipates further announcements in this regard in the coming quarters.
Cannabis One Commenced Trading Last Week
Quinsam invested $341,550 in Cannabis One Holdings Inc. last year at an equivalent price of $0.50 per unit
(share and a half warrant at $0.75). Cannabis One shares recently traded at $2.50.
Cannabis One is a Colorado based corporation that provides various support services and infrastructure development to licensed
producers of cannabis in the States of Colorado, Nevada and Washington. Cannabis One has licensing agreements and contractual
partnerships with unrelated licensed cannabis producing entities to provide a variety of services including product packaging,
equipment leasing, and site personnel and management resources. It also owns certain intellectual property, including the
trademarks, domain names and/or licensing rights for various cannabis related brands within the State of Colorado, including the
trademark, trade name and domain names for the cannabis production brand “CannabisTM”, for the retail locations known as “The
JointTM” and for the innovative vape style cannabis delivery system known as “INDVRTM”.
Osoyoos Cannabis Commenced Trading
Osoyoos Cannabis Inc., in which we invested in $500,000 in convertible debentures, commenced trading in
February. Our debentures convert at $0.15 and we also had warrant coverage. Osoyoos is pursuing an oil extraction and
outdoor grow strategy and is currently in the licensing process. The shares are currently trading at approximately $0.25,
which is lower than the $0.45 price at which the company last raised funds (and where we most recently pegged the value of our
investment). However, we remain pleased with out investment in Osoyoos and at this time plan on retaining our
position.
Abacus Health Products Commenced Trading
Abacus Health Products, in which we invested $300,000 at $3.75 per share, has a growing line of FDA-approved CBD
products on the market in the United States. The company had a very successful trading debut about a month ago and now trades
in the $11 area.
“Apart from these developments, as previously announced we saw a very positive liquidity event in Q1/2019 by
Westleaf Inc.” said Roger Dent, CEO of Quinsam. “This stock continues to trade very well. We have also seen very
nice moves in our holdings in Halo Labs Inc. and C21 Investments Inc. Halo has released very positive January and February
sales data. As expected, C21 has recovered from the severe pressure that was brought about by the convertible debenture unit
offering in which we participated. Not surprisingly, we have seen a decline in Cannamerica Brands Corp. following the expiry
of the hold on its new issue shares. Overall, we remain pleased with progress in Q1/2019 to date.”
About Quinsam Capital Corporation
Quinsam is a merchant bank based in Canada that is focusing on cannabis-related investments. Our merchant
banking business may encompass a range of activities including acquisitions, advisory services, lending activities and portfolio
investments. Quinsam invests its capital for its own account in assets, companies or projects which we believe are undervalued and
where we see a viable plan for unlocking such value. We do not invest on behalf of any third party and we do not offer investment
advice.
Generally, Quinsam does not believe that individual investments are material reportable events. Quinsam
chooses to announce certain investments once the company is certain that it has finished buying its position because the Company
feels that this information helps Quinsam’s investors understand its investment decision making process. Generally, Quinsam
does not announce the sale of investments.
For further information please contact:
Roger Dent, CEO
(647) 993-5475
roger@quinsamcapital.com
This press release may contain forward-looking statements relating to anticipated future events, results,
circumstances, performance or expectations that are not historical facts but instead represent our beliefs regarding future events,
which are inherently uncertain. Forward-looking statements can often, but not always, be identified by forward-looking words such
as “anticipate”, “believe”, “continue”, “expect”, “goal”, “plan”, “intend”, “estimate”, “may”, “project”, “predict”, “potential”,
“target”, and “will” or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions,
intentions or statements about future events or performance.
By their nature, forward-looking statements require us to make assumptions which include, among other things,
that (i) Quinsam will have sufficient capital under management to effect its business strategies, (ii) the business strategies will
produce the results intended by Quinsam, and (iii) the markets will react and perform in a manner consistent with the business
strategies.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause
actual results or events to differ materially from those anticipated in such forward-looking information. The Company believes that
the expectations reflected in the forward-looking information are reasonable but no assurance can be given that these expectations
will prove to be correct. Some of the risks and other factors that could cause actual results to differ materially from those
expressed in forward-looking information expressed in this press release include, but are not limited to: cannabis companies
Quinsam has invested in obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other
licenses, and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as
changes in applicable laws and regulations, including U.S. state-law legalization; market and general economic conditions of the
cannabis sector or otherwise, interest rates, regulatory and statutory developments, the nature of the Company’s investments, the
available opportunities and competition for investments, the concentration of the Company’s investments in certain industries
and sectors, reliance on key personnel, risks affecting the Company’s investments, management of the growth of the Company, and
exchange rate fluctuations. Readers are cautioned that the foregoing list of risks and factors is not exhaustive. Although the
Company has attempted to identify important factors that could cause actual events or results to differ materially from those
described in forward-looking information, there may be other factors that cause events or results to differ from those intended,
anticipated or estimated.
The forward-looking information contained herein is provided as at the date of this press release, based upon
the opinions and estimates of management and information available to management as at the date of this press release. The Company
does not undertake and specifically disclaims any intention or obligation to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise, unless required by applicable law. Readers are cautioned not to
place undue reliance on forward-looking information contained in this press release.
